Bristol-Myers, OXB sign multi-year CAR-T supply deal
Source: SeekingAlpha
2026-02-04 06:47:56 ET
More on Bristol-Myers Squibb
- Bristol Myers Squibb: The Rerating Was Fast - The Proof Will Be Slow (Rating Downgrade)
- Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion
- 44th Annual J.P. Morgan Healthcare Conference
- FDA launches PreCheck program to assist in building pharma plants
- Earnings week ahead: AMZN, GOOG, PLTR, AMD, PFE, DIS, PYPL, ABBV, QCOM, SMCI, MRK, PEP, UBER, PM, and more
Read the full article on Seeking Alpha
For further details see:
Bristol-Myers, OXB sign multi-year CAR-T supply deal
Oxford Biomedica
NASDAQ: OXBDF
OXBDF Trading
0.0% G/L:
$8.17 Last:
190 Volume:
$8.17 Open:
OXBDF Latest News
OXBDF Stock Data
$1,368,841,070
56,654,274
43.3%
1
N/A
Biotechnology & Life Sciences
Healthcare
GB
Oxford
